Breaking News

You are here » Indian-Commodity  :  Top News  :  Zydus receives USFDA's nod for Dutasteride and Tamsulosin Hydrochloride Capsules

25-May2018

Zydus receives USFDA's nod for Dutasteride and Tamsulosin Hydrochloride Capsules

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Dutasteride and Tamsulosin Hydrochloride Capsules, 0.5 mg/0.4 mg. The drug is used to treat symptoms of Benign Prostatic Hyperplasia (BPH). It will be manufactured at the group's manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 190 approvals and has so far filed over 320 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies


Related News

View all news

Gold futures end higher on Monday

Gold futures ended higher on Monday, marking its highest rate since late July due to increased safe haven investments amidst of crash in global equity markets and geo-political tensions. Meanwhile, weakness......

Nickel futures decline on muted demand

Nickel futures declined on MCX as participants cut down their bets amid muted demand from alloy-makers and other consuming industries at the spot market. The contract for October delivery was trading at......

Physical Rubber prices witness weakness on Monday

Physical Rubber prices showed weakness on Monday. Spot prices for RSS-4 variety fell to Rs 127.50/ kg compared to its previous closing of Rs 128/ kg; while the RSS-5 variety declined to Rs 122.50/ kg compared......

Top News

View all news

Shalimar Paints lays down foundation of Nashik manufacturing plant

Shalimar Paints has laid down the foundation of a manufacturing unit to be rebuilt in Nashik, in the state of Maharashtra. The company set to commence operations by April 2019 with a planned production......

Delta Corp reports 11% rise in Q2 consolidated net profit

Delta Corp has reported results for second quarter ended September 30, 2018.The company has reported over 2-fold jump in its net profit at Rs 63.51 crore for the quarter under review as compared to Rs......

PNB plans to sell non-core assets worth Rs 8,600 crore during FY19

Punjab National Bank (PNB) has recognized various assets, including its housing finance arm, for sale and hopes to realise Rs 8,600 crore from these non-core assets during the current fiscal. Meanwhile,......